Interferon lambda-1 (IFN-l1), the prototype Type-III interferon, has antiviral functions similar to those of the Type-I interferons, IFN-a and IFN-b. However, IFN-l1 is capable of signaling through almost all STAT molecules and so it is possible that it may have novel immunoregulatory functions in addition to antiviral ones. From a range of chemokines tested, IFN-l1 elevated mRNA levels of only 'Monokine induced by IFN-gamma' (MIG/CXCL9), 'IFN-gamma inducible protein-10' (IP-10/CXCL10) and 'IFN-gamma inducible T-cell a chemoattractant' (I-TAC/CXCL11) from human peripheral blood mononuclear cells. As their names suggest, these chemokines are also induced by IFN-g, the only member of the Type-II interferon family. This action of IFN-l1 did not depend on intermediate induction of IFN-g and is therefore, likely to be independent of IFN-g. Further, our results suggest that donors responded to IFN-l1 stimulation either 'early' or 'late'. Overall the action of IFN-l1 was similar to that previously reported for IFN-g and may invite more detailed investigation of the role of IFN-l1 at the innate/adaptive interface.
Interferons play a key role in both innate and adaptive immunity. 1 The type-I interferons IFN-a and IFN-b are expressed following viral infection or extracellular triggers such as toll-like receptor (TLR) engagement; 1, 2 their functions are often mediated through the phosphorylation of STAT1 and STAT2. [3] [4] [5] [6] IFN-g, the sole known Type-II interferon, is a common product of T-cells and NK cells and is a potent activator of macrophages, T-cells and other components of the adaptive immune response. 7, 8 Its functions are often mediated via the phosphorylation of STAT1 and STAT3, but it also activates STAT4, STAT5 and STAT6. 9 ,10 IFN-g also induces a range of chemokines. Chemokines are small, chemoattractant proteins (8-10 kDa) that play an important role in the recruitment and activation of leukocytes and therefore are necessary for the communication between the innate and adaptive arms of the immune system, particularly in a Th1 type response. [11] [12] [13] [14] Four subfamilies of chemokines (C, CC, CXC and CX 3 C) can be distinguished according to the arrangement of the first two cysteine residues, which may be adjacent (the 'CC' family) or separated by one or three amino acids (the 'CXC' and 'CX 3 C' families). 15, 16 IFN-g induces a limited range of chemokines, 17 notably MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11). 13, 18 These chemokines all signal through the CXCR3 receptor; this is expressed on activated T cells, particularly Th1 cells. [19] [20] [21] These chemokines are distinct in that they are members of the so-called 'ELR À ' subfamily of CXC chemokines (lacking the tripeptide motif 'Glu-Leu-Arg; E-L-R'). They are potent chemoattractants for mononuclear cells and they are also characteristically defensin-like and have antimicrobial activities. MIG, I-TAC and IP-10 also display inhibitory effects on angiogenesis, contrasting with the CXC (and ELR þ ) chemokines such as IL-8, which are chemoattractants for neutrophils and promote angiogenesis. 17 Recently, a new family of interferons was discovered, the Type-III interferons. These are known as IFN-l1, 2 and 3 (or alternatively, IL-29, IL-28a and IL-28b, respectively). IFN-l1 was first described as having modest similarity to IFN-a 22 and soon led to the discovery of the three ligand members of the family and their unique receptor complex, which comprises the previously unknown CRF2-12 chain (IL-28Ra) and the CRF2-4 chain (IL-10Rb). 23, 24 Like the Type-I interferons, the interferons lambda are induced by viral infections as well as by a range of mitogens. IFN-l1 (and by association IFN-l2 and 3) uses STAT1 and STAT2 phosphorylation to mediate Type-I IFN-like functions such as upregulation of MHC class-I and induction of OAS-1. 23 Numerous reports have verified the antiviral and Type-I IFN-like function of IFN-l1, 1, 2, 25 although it is recognized as being weaker than Type-I IFN in this respect. 24 Interestingly, IFN-l1 signaling also leads to the phosphorylation of STAT3, similarly to the action of IFN-g. 9 This observation led us to ask whether IFN-l1 had immunoregulatory functions to complement its recognized Type-I interferon-like actions. Such functions may be reminiscent of IFN-g and raise the question of interaction or interdependence of IFN-l1 and IFN-g.
We examined the levels of mRNA for the three key ELR À chemokines described above, MIG, IP-10 and I-TAC, in human peripheral blood mononuclear cells (PBMC) following stimulation in vitro with IFN-l1. Other chemokines (MIP-1a, MIP-1b, RANTES, MCP-1 and ENA-78) were not affected by IFN-l1. In addition, we examined the effect of IFN-l1 on levels of IFN-g mRNA. Eight donors were examined in the present preliminary study. PBMCs were established in culture in the presence or absence of 1000 ng/ml (as described previously by Jordan et al.
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) human IFN-l1 (Peprotech, Princeton, NJ, USA) over a time course covering 15, 30, 60, 90, 120, 180 and 240 min, and 24, 48 and 72 h. Cells were harvested, total RNA extracted (Qiagen, Valencia, CA, USA) and the levels of MIG, IP-10 and I-TAC mRNA determined by quantitative reverse transcription PCR (Q-RTPCR) relative to the housekeeping gene HPRT. The change in chemokine mRNA levels caused by exposure to IFN-l1 are shown in Figure 1 . It was noted that chemokine levels in all donors rose by varying degrees in response to IFNl1 exposure and in one case by up to a factor of 1000-fold (donor 1, I-TAC, data not shown).
In addition, we observed that donors appeared to be 'early' or 'late' responders to IFN-l1. 'Early' responders showed peak chemokine mRNA levels between 15 and 240 min, while 'late' responders peaked between 24 and 72 h. Donors no. 2 and no. 5 are shown in Figure 1 as examples of the transcriptional patterns 'early' and 'late', respectively; six of eight donors fell clearly into this pattern, while two showed a more mixed chemokine expression pattern
As shown in Table 1 6 cells were cultured in 24-well plates in a 1 ml final volume containing IFN-l1 (0-1000 ng/ml). Cells were incubated at 371C for varying times as described in the text. Supernatants were harvested and stored at À201C. Total RNA was extracted from PBMC (Qiagen) and converted to cDNA with MMLV Reverse Transcriptase (Applied Biosystems). Levels of mRNA were assayed using the M Â 4000 quantitative PCR system (Stratagene). Primers sequences for the chemokines MIG, I-TAC, and IP-10 were used according to Hayashi et al. Abbreviations: IFN-g, interferon gamma; IFN-l1, interferon lambda-1. Peak mRNA levels of chemokines were reached earlier or at the same time point as IFN-g peak mRNA levels and peak IFN-g protein levels, thus demonstrating the independence of IFN-l1's effects on these chemokines. IFN-g protein levels were detected at late time points. Only time points displaying measurable IFN-g protein levels are shown. PBMC and supernatants were harvested from donors as described for Figure 1 . Secreted IFN-g protein levels were measured by ELISA as previously described by Jordan et al. 32 No IFN-g protein levels were detected before 24 h. Q-RTPCR for IFN-g mRNA was conducted as described for the chemokines, using the following primers: IFN-g (NM_700219) Fwd-CCA.ACG.CAA.AGC.AAT.ACA.TGA, Rev-CGC.TTC.CCT.GTT.TTA.GCT.GC. (1/8) , while the three late responders all peaked at 24 h. Thus, the elevation of ELR À CXC chemokine mRNA by IFN-l1 appeared relatively distinct, however, 2/8 donors showed elements of both the late and the early IFN-l1 response. This is in keeping with previously published data demonstrating that the expression of chemokines may vary, even though they share the same receptor. 27 From these data, we can infer that donors can be classified generally as early or late responders to IFN-l1 with respect to MIG, IP-10 and I-TAC expression. One may speculate that this reflects a broad tendency of some donors to innate (early) or adaptive (late) responses. ELR À chemokines have been implicated in the innate immune response 28 and our data are supportive of this by showing that 15/24 (63%) of the mRNA levels reached maximal levels within the early phase. While the maximal concentration of IFN-l1 used (1000 ng/ml) is shown here, dose response experiments showed detectable responses as low as 10 ng/ml.
Induction of ELR
We have shown that MIG, IP-10 and I-TAC could be upregulated by IFN-l1. However, since these are known to be upregulated by IFN-g, we investigated whether the IFN-l1-mediated mRNA elevation might be driven indirectly, via IFN-l1 induction of IFN-g. Were this to be the case, we expected that the peak mRNA levels for IFN-g would be before those for the three chemokines studied. The opposite was true; for each donor, irrespective of their early or late responder status, IFN-g mRNA levels were maximal at or after the expression peak of the earliest chemokine. Furthermore, when we examined the levels of IFN-l protein by enzyme-linked immunosorbent assay, every donor showed IFN-g peak levels after their maximal chemokine mRNA level; indeed, no IFN-g protein was measurable before 24 h (Table 1 ).
In conclusion, we have shown that the novel Type-III interferon, IFN-l1, can induce the expression of mRNA for three ELR À CXC chemokines, MIG, IP-10 and I-TAC in human PBMCs in the absence of other stimuli. While these chemokines may be induced by IFN-g, we have shown that their induction by IFN-l1 is most likely to be independent of IFN-g. In addition, we have demonstrated that individuals may fall into two groups regarding IFN-l1-mediated chemokine induction, early or late. Finally, we have shown that human PBMCs will respond to IFN-l1 by expressing and secreting IFN-g, but that this response is uniformly late, with secretion occurring around 24 h. These data complement previous reports which demonstrated an increase of IFN-g in virally infected cells following IFNl1 treatment. 29 Future studies will be directed towards greater understanding of the immumomodulatory role of IFN-l1 in the human system. It will be of interest to determine which leukocyte populations are most responsive to IFN-l1 regarding CXC ELR À chemokine production (we have shown previously that monocytes are particularly responsive for cytokine secretion 26 ) and to define any cooperative effects between IFN-l1 and IFN-g.
